Wells Fargo & Company Ironwood Pharmaceuticals Inc Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Wells Fargo & Company holds 51,290 shares of IRWD stock, worth $361,081. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,290

Previous 44,430 15.44%

Holding current value

$361,081

Previous $508,000 12.2%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$8.32 - $15.45 $57,075 - $105,987	6,860 Added 15.44%	51,290 $446,000
Q4 2023 Feb 09, 2024	SELL	$8.79 - $11.51 $1.32 Million - $1.73 Million	-150,708 Reduced 77.23%	44,430 $508,000
Q3 2023 Nov 13, 2023	BUY	$8.25 - $11.35 $38,040 - $52,334	4,611 Added 2.42%	195,138 $1.88 Million
Q2 2023 Aug 15, 2023	BUY	$10.1 - $11.6 $485,577 - $557,693	48,077 Added 33.75%	190,527 $2.03 Million
Q1 2023 May 12, 2023	BUY	$10.37 - $12.56 $493,103 - $597,240	47,551 Added 50.11%	142,450 $1.5 Million

Q4 2022 Feb 13, 2023	SELL	$9.9 - $12.43 $73,636 - $92,454	-7,438 Reduced 7.27%	94,899 $1.18 Million
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $1.44 Million - $1.75 Million	-141,530 Reduced 58.04%	102,337 $1.06 Million
Q2 2022 Aug 12, 2022	SELL	$11.05 - $12.72 $3.37 Million - $3.88 Million	-304,914 Reduced 55.56%	243,867 $2.81 Million
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $460,675 - $559,236	-43,419 Reduced 7.33%	548,781 $6.9 Million
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $7.65 Million - $9.83 Million	-704,839 Reduced 54.34%	592,200 $6.91 Million
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $4.01 Million - $4.68 Million	336,513 Added 35.03%	1,297,039 $16.9 Million
Q2 2021 Aug 16, 2021	BUY	$10.16 - $13.11 $4.14 Million - $5.35 Million	407,825 Added 73.79%	960,526 $12.4 Million
Q1 2021 May 13, 2021	BUY	$9.04 - $11.86 $1.33 Million - $1.75 Million	147,556 Added 36.42%	552,701 $6.18 Million
Q4 2020 Feb 09, 2021	SELL	$9.05 - $12.2 $285,337 - $384,653	-31,529 Reduced 7.22%	405,145 $4.62 Million
Q3 2020 Nov 05, 2020	SELL	$8.99 - $10.74 $83,544 - $99,806	-9,293 Reduced 2.08%	436,674 $3.93 Million
Q2 2020 Aug 13, 2020	BUY	$9.14 - $11.97 $1.04 Million - $1.36 Million	113,364 Added 34.08%	445,967 $4.6 Million
Q1 2020 May 14, 2020	BUY	$8.58 - $14.01 $2.85 Million - $4.66 Million	332,603 New	332,603 $3.36 Million

Others Institutions Holding IRWD

# of Institutions

292

Shares Held

170M

Call Options Held

27.1M

Put Options Held

2.28M

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $1.08B
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Ironwood Pharmaceuticals Inc Transaction History